Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Tax Provisions (2016 - 2025)

Pediatrix Medical (MD) has disclosed Tax Provisions for 17 consecutive years, with $16.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Tax Provisions rose 177.36% to $16.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $44.1 million, a 251.24% increase, with the full-year FY2024 number at -$106000.0, down 104.17% from a year prior.
  • Tax Provisions was $16.1 million for Q3 2025 at Pediatrix Medical, up from $15.7 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $16.1 million in Q3 2025 to a low of -$24.1 million in Q4 2023.
  • A 5-year average of $4.6 million and a median of $7.4 million in 2025 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: tumbled 729.45% in 2023, then surged 206.84% in 2025.
  • Pediatrix Medical's Tax Provisions stood at $13.2 million in 2021, then crashed by 71.12% to $3.8 million in 2022, then crashed by 729.45% to -$24.1 million in 2023, then soared by 120.83% to $5.0 million in 2024, then soared by 220.5% to $16.1 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Tax Provisions are $16.1 million (Q3 2025), $15.7 million (Q2 2025), and $7.4 million (Q1 2025).